These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16380971)

  • 1. Electrostatic interactions of peptides flanking the tyrosine kinase domain in the epidermal growth factor receptor provides a model for intracellular dimerization and autophosphorylation.
    Aifa S; Miled N; Frikha F; Aniba MR; Svensson SP; Rebai A
    Proteins; 2006 Mar; 62(4):1036-43. PubMed ID: 16380971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A basic peptide within the juxtamembrane region is required for EGF receptor dimerization.
    Aifa S; Aydin J; Nordvall G; Lundström I; Svensson SP; Hermanson O
    Exp Cell Res; 2005 Jan; 302(1):108-14. PubMed ID: 15541730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region.
    Poppleton HM; Wiepz GJ; Bertics PJ; Patel TB
    Arch Biochem Biophys; 1999 Mar; 363(2):227-36. PubMed ID: 10068444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The juxtamembrane region of the epidermal growth factor receptor is required for phosphorylation of Galpha(s).
    Poppleton HM; Sun H; Mullenix JB; Wiepz GJ; Bertics PJ; Patel TB
    Arch Biochem Biophys; 2000 Nov; 383(2):309-17. PubMed ID: 11185568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?
    Groenen LC; Walker F; Burgess AW; Treutlein HR
    Biochemistry; 1997 Apr; 36(13):3826-36. PubMed ID: 9092812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of Thr654 but not Thr669 within the juxtamembrane domain of the EGF receptor inhibits calmodulin binding.
    Aifa S; Frikha F; Miled N; Johansen K; Lundström I; Svensson SP
    Biochem Biophys Res Commun; 2006 Aug; 347(2):381-7. PubMed ID: 16793002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
    Zhang X; Gureasko J; Shen K; Cole PA; Kuriyan J
    Cell; 2006 Jun; 125(6):1137-49. PubMed ID: 16777603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical investigations of prostatic acid phosphatase.
    Sharma S; Pirilä P; Kaija H; Porvari K; Vihko P; Juffer AH
    Proteins; 2005 Feb; 58(2):295-308. PubMed ID: 15578709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-autophosphorylation of juxtamembrane tyrosines in the insulin receptor kinase domain.
    Cann AD; Kohanski RA
    Biochemistry; 1997 Jun; 36(25):7681-9. PubMed ID: 9201908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.
    McLaughlin S; Smith SO; Hayman MJ; Murray D
    J Gen Physiol; 2005 Jul; 126(1):41-53. PubMed ID: 15955874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational regulation of the EGFR kinase core by the juxtamembrane and C-terminal tail: a molecular dynamics study.
    Mustafa M; Mirza A; Kannan N
    Proteins; 2011 Jan; 79(1):99-114. PubMed ID: 20938978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains.
    Landau M; Fleishman SJ; Ben-Tal N
    Structure; 2004 Dec; 12(12):2265-75. PubMed ID: 15576039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein tyrosine kinase-substrate interactions.
    Bose R; Holbert MA; Pickin KA; Cole PA
    Curr Opin Struct Biol; 2006 Dec; 16(6):668-75. PubMed ID: 17085043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the membrane reconstituted transmembrane-juxtamembrane peptide EGFR(622-660) and its interaction with Ca2+/calmodulin.
    Sato T; Pallavi P; Golebiewska U; McLaughlin S; Smith SO
    Biochemistry; 2006 Oct; 45(42):12704-14. PubMed ID: 17042488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
    Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
    Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential and synergistic effects of epidermal growth factor receptor antibodies on unliganded ErbB dimers and oligomers.
    Kozer N; Kelly MP; Orchard S; Burgess AW; Scott AM; Clayton AH
    Biochemistry; 2011 May; 50(18):3581-90. PubMed ID: 21495621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and inactive conformations of the epidermal growth factor receptor.
    Ferguson KM
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):742-5. PubMed ID: 15494003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational dynamics of the EGFR kinase domain reveals structural features involved in activation.
    Papakyriakou A; Vourloumis D; Tzortzatou-Stathopoulou F; Karpusas M
    Proteins; 2009 Aug; 76(2):375-86. PubMed ID: 19173306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the extracellular region of HER3 reveals an interdomain tether.
    Cho HS; Leahy DJ
    Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis.
    Wang Q; Zhu F; Wang Z
    Exp Cell Res; 2007 Sep; 313(15):3349-63. PubMed ID: 17643422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.